¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"asymmetric ventricular hypertrophy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • false hypertrophy
    °ÅÁþºñ´ë
  • gum hypertrophy
    ÀÕ¸öºñ´ë
  • hypertrophy
    ºñ´ë
  • idiopathic myocardial hypertrophy
    Ư¹ß½É±Ùºñ´ë, ¿øÀκҸí½É±Ùºñ´ë
  • physiologic hypertrophy
    »ý¸®Àûºñ´ë
  • papillomatous hypertrophy
    À¯µÎÁ¾¸ð¾çºñ´ë
  • pseudomuscular hypertrophy
    °ÅÁþ±ÙÀ°ºñ´ë, °¡¼º±ÙÀ°ºñ´ë
  • vicarious hypertrophy
    ´ë»óºñ´ë
  • bidirectional ventricular tachycardia
    ¾ç¹æÇâ½É½Çºü¸¥¸Æ, ¾ç¹æÇâ½É½Ç(¼º)ºó¸Æ
  • escaped ventricular contraction
    ÀÌÅ»½É½Ç¼öÃà
  • left ventricular failure
    ¿Þ½É½Ç±â´É»ó½Ç, Á½ɽǺÎÀü
  • premature ventricular contraction
    Á¶±â½É½Ç¼öÃà
  • right ventricular failure
    ¿À¸¥½É½Ç±â´É»ó½Ç, ¿ì½É½ÇºÎÀü
  • right ventricular strain
    ¿ì½É½Ç±äÀå, ¿À¸¥½É½Ç±äÀå
  • ventricular
    1. ½É½Ç- 2. ³ú½Ç-
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • concentric hypertrophy
    µ¿½Éºñ´ë
  • denture hypertrophy
    ÀÇÄ¡Á¶Á÷ºñ´ë
  • false hypertrophy
    °ÅÁþºñ´ë
  • hypertrophy
    ºñ´ë
  • idiopathic myocardial hypertrophy
    Ư¹ß½É±Ùºñ´ë, ¿øÀκҸí½É±Ùºñ´ë
  • papillomatous hypertrophy
    À¯µÎÁ¾¸ð¾çºñ´ë
  • physiologic hypertrophy
    »ý¸®Àûºñ´ë
  • pseudomuscular hypertrophy
    °ÅÁþ±ÙÀ°ºñ´ë
  • symmetric hypertrophy
    ´ëĪºñ´ë
  • true hypertrophy
    Áø¼ººñ´ë
  • vicarious hypertrophy
    ´ë»óºñ´ë
  • nail hypertrophy onychauxis
    ¼Õ¹ßÅéºñ´ë
  • ventricular activation
    ½É½ÇÈïºÐ
  • ventricular aneurysm
    ½É½ÇÀÚ·ç, ½É½Ç·ù
  • ventricular arrhythmia
    ½É½ÇºÎÁ¤¸Æ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hypertrophy of dental root
    Ä¡Àººñ´ë.
  • hypertrophy of right ventricle
    ¿À¸¥½É½Çºñ´ëÁõ
  • hypertrophy of the palatine tonsil
    ±¸°³Æíµµºñ´ëÁõ
  • hypertrophy, cardiac
    ½ÉÀåºñÈÄ.
  • hypertrophy, cicatricial
    ¹ÝÈ缺 ºñÈÄ.
  • hypertrophy, compensatory
    ´ë»ó¼º ºñ´ë.
  • idiopathic myocardial hypertrophy
    Ư¹ß¼º ½É±Ùºñ´ëÁõ.
  • physiologic hypertrophy
    »ý¸®Àû ºñ´ë (¡­îÜÝþÓÞ).
  • physiologic hypertrophy
    »ý¸®Àû ºñ´ë(ßæ×âîÜ ÝþÓÞ)
  • prostatic hypertrophy
    Àü¸³¼±ºñ´ë.
  • prostatic hypertrophy
    Àü¸³¼±ºñ´ë(îñí¡àÍÝþÓÞ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • asymmetric compound
    ºñ´ëĪȭÇÕ¹°.
  • asymmetric density
    ºñ´ëμº À½¿µ
  • asymmetric gaze nystagmus
    ºñ´ëĪÁֽþÈÁø
  • asymmetric respiration
    ºñ´ëĪȣÈí.
  • asymmetric twin
    ºñ´ëνÖžÆ
  • asymmetric(al)
    ºñ´ëĪÀÇ.
  • asymmetric(al) antivitamin K
    ºñ´ëĪÇ׺ñŸ¹Î K.
  • asymmetric(al) carbon atom
    ºñ´ëĪź¼Ò¿øÀÚ.
  • asymmetric(al) synthesis
    ºÒ±ÕµîÇÕ¼º.
  • subacute asymmetric idiopathic polyneuritis
    ¾Æ±Þ¼º ºñ´ëμº Ư¹ß¼º ´Ù¹ß½Å°æ¿°(¡­ÞªÓßöààõ÷åÛ¡àõÒýÛ¡ãêÌèæú).
  • subacute asymmetric idiopathic polyneuritis
    ¾Æ±Þ¼º ºñ´ëμº Ư¹ß¼º ´Ù¹ß½Å°æ¿°(¡­ÞªÓßöààõ÷åÛ¡àõÒýÛ¡ãêÌèæú)
  • asymmetry (unilateral hypertrophy)
    ºñ´ëĪ(ÇÑÂʺñ´ë)
  • atrial hypertrophy
    ½É¹æºñ´ë(ãýÛ®ÝþÓÞ).
  • benign prostatic hypertrophy
    ¾ç¼ºÀü¸³¼±ºñ´ë(Áõ)(¡­îñí¡àÊÝþÓÞñø).
  • big heel =endemic hypertrophy of os calcis
    ºñÈÄ Á¾ºÎ(Ýþý§ñ¢Ý»), Á¾ºÎ Áö¹æ¼º ºñÈÄ(ñ¢Ý»ò¢Û°àõÝþý§), Å« µÚ²ÞÄ¡, À¯Ç༺ Á¾°ñÁ¾·ù(¡­ñ¢Íéðþ×»).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
LVH Left Ventricular Hypertrophy
RVH Right Ventricular Hypertrophy
VH Ventricular Hypertrophy
CVH cerebroventricular hemorrhage; cervicovaginal hood; combined ventricular hypertrophy; common variabl...
LVH large vessel hematocrit; left ventricular hypertrophy
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ASH Asymmetrical septal hypertrophy
B.P.H. Benign Prostatic Hypertrophy
COH Compensatory ovarian hypertrophy
CHRPE Congenital hypertrophy of the retinal pigment epithelium
LVH LV hypertrophy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • left ventricular end-diastolic volume
    Á ½É½Ç À̿ϱ⸻ ¿ëÀû
  • left ventricular failure
    Á ½É½Ç ºÎÀü
  • left ventricular outflow tract stenosis
    Á ½É½Ç À¯Ãâ·Î ÇùÂø
  • left ventricular pressure
    Á ½Ç¾Ð, Á ½É½Ç ¾Ð
    Á ½É½Ç¿¡¼­ ´ëµ¿¸ÆÀ¸·Î ÇǸ¦ º¸³»°Ô ÇÏ´Â ¿øµ¿·Â.
  • left ventricular strain
    ÁÂ½Ç ±äÀå, ÁÂ½É½Ç ±äÀå
  • right ventricular failure
    ¿ì ½É½Ç ºÎÀü
  • right ventricular strain
    ¿ì ½É½Ç ±äÀå
  • ventricular
    ½É½ÇÀÇ
    ½É½Ç¿¡ °üÇÑ.
  • ventricular fibrillation
    ½É½Ç ¼¼µ¿
    ½ÉÀåÀÇ ¹Úµ¿¿¡¼­ ½É½ÇÀÇ °¢ ºÎºÐÀÌ ¹«Áú¼­ÇÏ°Ô ºÒ±ÔÄ¢ÀûÀ¸·Î ¼öÃàÇÏ´Â »óÅÂ. ¼öÃàÀÇ ºóµµ, Áï ½ÉÀüµµ»óÀÇ ÆÄ»óÀÌ ¸ÅºÐ 170¡­300ÀÎ °ÍÀ» Á¶µ¿, 300¡­600ÀÎ °ÍÀ» ¼¼µ¿À̶ó ÇÏ¿© ±¸º°ÇÏ´Â °æ¿ìµµ ÀÖÀ¸³ª, ½É½Ç Á¶µ¿¿¡´Â Áֱ⿡ È®½ÇÇÑ ±ÔÄ¢¼ºÀÌ ¾øÀ¸¹Ç·Î ½É½Ç¿¡ °üÇÏ¿© ¼¼µ¿°ú Á¶µ¿ »çÀÌ¿¡´Â ¶Ñ·ÇÇÑ ±¸º°ÀÌ ¾ø´Ù. ½É½Ç ¼¼µ¿ÀÏ ¶§´Â ½É½Ç¿¡¼­ Ç÷¾×ÀÌ ¹ÚÃâµÇÁö ¾ÊÀ¸¹Ç·Î ¼øÈ¯ºÎÀüÀ» ÀÏÀ¸ÄѼ­ »ç¸ÁÇÏ°Ô µÈ´Ù. À̶§´Â ½ÉÀå ¸¶»çÁö¸¦ Çϰųª Á¦¼¼µ¿±â¿¡ ÀÇÇÏ¿© ¼¼µ¿À» Á¦°ÅÇØ¾ß ÇÑ´Ù.
  • ventricular gallop
    ½É½Ç¼º °¶·´, ½É½Ç¼º ºÐ¸¶À²
  • ventricular septal defect
    ½É½Ç Áß°Ý °á¼Õ
    ¼±Ãµ¼º ½ÉÁúȯ¿¡¼­ ºóµµ°¡ ³ôÀº °ÍÀÇ ÇϳªÀÌ´Ù. ½É½Ç Áß°Ý¿¡ °á¼ÕÀÌ ÀÖ´Â °ÍÀ» ¸»ÇÑ´Ù. º¸Åë ½É½Ç Áß°Ý ¸·¼º ºÎÀ§ÀÇ °á¼ÕÀε¥ ±Ù¼º ºÎÀ§¿¡ °á¼ÕÀÌ ÀÖ´Â °Íµµ ÀÖ´Ù. °á¼Õ°øÀÇ Å©±â´Â ´Ù¾çÇÏ´Ù. ÀϹÝÀûÀ¸·Î ¿¹ÈÄ´Â ¾çÈ£Çϰí ÀÚ¿¬ Æó¼âµµ ÀÖ´Ù. Ä¡·á´Â ¿Ü°úÀûÀ¸·Î Æó¼â¸¦ ÇÑ´Ù.
  • ventricular vein
    ½É½Ç Á¤¸Æ
  • adaptive hypertrophy
    ¼øÀÀ¼º ºñ´ë
    »óÅÂÀÇ º¯È­¿¡ ÀÇÇÏ¿© Å©±â°¡ Áõ°¡ÇÏ´Â °Í.
  • adenoidal hypertrophy
    ¾Æµ¥³ëÀÌµå ºñ´ëÁõ
  • benign masseteric hypertrophy
    ¾ç¼º ±³±Ù ºñ´ë
    ¿øÀÎ ºÒ¸íÀÇ ÁúȯÀ¸·Î¼­, º¸Åë ¾çÃø¼ºÀ¸·Î ±³±ÙÀÇ Å©±â°¡ ºñ¾Ç¼ºÀ¸·Î Áõ°¡ÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
compensatory hypertrophy of the heart Thickening of the walls of the heart in response to vascular, valvular, other heart disease, or athletic conditioning.
(05 Mar 2000)
complementary hypertrophy Increase in size or expansion of part of an organ or tissue to fill the space left by the destruction of another portion of the same organ or tissue.
(05 Mar 2000)
concentric hypertrophy Thickening of the walls of the heart or any cavity with apparent diminution of the capacity of the cavity.
(05 Mar 2000)
haemangiectatic hypertrophy <syndrome> A congenital malformation syndrome characterised by the triad of asymmetric limb hypertrophy, haemangiomata, and nevi. Asymmetric limb hypertrophy is enlargement of one limb and not the corresponding limb on the other side, the enlarged limb being 3 times more likely to be a leg than an arm in ktw; and the limb enlargement is of bone as well as soft tissue. The haemangiomas, abnormal nests of blood vessels that proliferate inappropriately and excessively, cover a remarkable range from small innocuous capillary haemangiomas ( strawberry marks ) to huge cavernous haemangiomas. The nevi are pigmented moles on the skin; in ktw there are often also dark linear streaks on the skin, streaks due to too much pigment. There can be other abnormalities but the triad is the consistent clinical centrepiece of the disease. most persons with ktw have an enlarged leg and do relatively well without treatment or, for example, with only compression from an elastic stocking. Skin ulcers and other skin problems can occur over the swollen leg. Usually, the treatment is conservative. Surgery is almost never needed. The only possible exceptions are the very rare situations in which the leg reaches gigantic proportions or secondary clotting difficulties arise (due to trapping and destruction of blood platelets in a huge haemangioma). Then, amputation may become necessary. The cause of ktw syndrome is unknown.
(12 Dec 1998)
simple hypertrophy Increase in size of cells.
(05 Mar 2000)
simulated hypertrophy Increased size of a part due to continued growth unrestrained by attritions, as is seen in the case of the teeth of certain animals when the opposing teeth have been destroyed.
(05 Mar 2000)
hypertrophy The enlargement or overgrowth of an organ or part due to an increase in size of its constituent cells.
Compare: hyperplasia.
Origin: Gr. Troph = nutrition
(18 Nov 1997)
numerical hypertrophy <pathology> The abnormal multiplication or increase in the number of normal cells in normal arrangement in a tissue.
Compare: hypertrophy.
Origin: Gr. Plasis = formation
(18 Nov 1997)
quantitative hypertrophy <pathology> The abnormal multiplication or increase in the number of normal cells in normal arrangement in a tissue.
Compare: hypertrophy.
Origin: Gr. Plasis = formation
(18 Nov 1997)
eccentric hypertrophy Thickening of the wall of the heart or other cavity, with dilation.
(05 Mar 2000)
endemic hypertrophy Enlargement of the calcaneus preceded by fever and pain in the heel, reported from the Gold Coast (now Ghana) and in Taiwan among the indigenous population.
(05 Mar 2000)
true hypertrophy An increase in size involving all the different tissues composing the part.
(05 Mar 2000)
false hypertrophy Increase in size of an organ or a part, due not to increase in size or number of the specific functional elements but to that of some other tissue, fatty or fibrous.
Synonym: false hypertrophy.
(05 Mar 2000)
functional hypertrophy Temporary increase in size of an organ or part to provide for a natural increase of function, such as the kind that occurs in the walls of the uterus and in the mammae during pregnancy.
Synonym: functional hypertrophy.
(05 Mar 2000)
lipomatous hypertrophy Nonencapsulated adipose tissue forming a lipoma-like mass, usually in the cardiac interatrial septum where it may cause arrhythmia and sudden death.
Synonym: lipomatous hypertrophy.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á